Recent Finacing
Recent Raise
Skyhawk Therapeutics develops small-molecule therapies that modulate RNA alternative splicing using its STAR* platform to rationally design sequence- and structure-specific RNA-binding compounds targeting exon-skipping diseases in neurology and oncology.
